Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-08

Clinical Trial Update: Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia [Phase 3]

View source ↗

Summary

Phase 3 trial update for corneal collagen crosslinking and Intacs in keratoconus and corneal ectasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corneal collagen crosslinking
  • Intacs (intrastromal corneal ring segments)

Snippet

Sponsor: Cornea and Laser Eye Institute | Conditions: Keratoconus, Corneal Ectasia | Phase 3 | Status: UNKNOWN